News
HC Wainwright & Co. Maintains Buy on Korro Bio, Raises Price Target to $115
28 Mar 24
News, Price Target, Analyst Ratings
Piper Sandler Maintains Overweight on Korro Bio, Maintains $180 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
RBC Capital Maintains Outperform on Korro Bio, Raises Price Target to $90
27 Mar 24
News, Price Target, Analyst Ratings
Korro FY23 EPS $(53.08) Vs $(227.42) YoY
26 Mar 24
Earnings, News
BMO Capital Reiterates Outperform on Korro Bio, Maintains $120 Price Target
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
RBC Capital Reiterates Outperform on Korro Bio, Maintains $70 Price Target
12 Mar 24
News, Price Target, Reiteration, Analyst Ratings
BMO Capital Initiates Coverage On Korro Bio with Outperform Rating, Announces Price Target of $120
27 Feb 24
News, Price Target, Initiation, Analyst Ratings
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
13 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $100 Price Target
19 Jan 24
News, Price Target, Reiteration, Analyst Ratings
Korro Bio Highlights Data For Its Lead Program In Alpha-1 Antitrypsin Deficiency And Progress Across Its RNA Editing Portfolio
18 Jan 24
Biotech, News, General
Press releases
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress
26 Mar 24
Earnings, Press Releases
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio
18 Jan 24
Press Releases, General
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
4 Jan 24
News, Press Releases